ATE443867T1 - METHOD FOR PREDICTING SEPSIS IN A PATIENT WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) - Google Patents

METHOD FOR PREDICTING SEPSIS IN A PATIENT WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)

Info

Publication number
ATE443867T1
ATE443867T1 AT03746054T AT03746054T ATE443867T1 AT E443867 T1 ATE443867 T1 AT E443867T1 AT 03746054 T AT03746054 T AT 03746054T AT 03746054 T AT03746054 T AT 03746054T AT E443867 T1 ATE443867 T1 AT E443867T1
Authority
AT
Austria
Prior art keywords
inflammatory response
sirs
patient
systemic inflammatory
response syndrome
Prior art date
Application number
AT03746054T
Other languages
German (de)
Inventor
Stephen Anderson
Douglas J Haney
Cory Waters
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE443867T1 publication Critical patent/ATE443867T1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G01N2333/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Diagnostic methods, systems, and kits for identifying patients with systemic inflammatory response syndrome who are likely to progress to sepsis.
AT03746054T 2002-04-02 2003-03-27 METHOD FOR PREDICTING SEPSIS IN A PATIENT WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) ATE443867T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37011502P 2002-04-02 2002-04-02
PCT/US2003/009351 WO2003084388A2 (en) 2002-04-02 2003-03-27 Early detection of sepsis

Publications (1)

Publication Number Publication Date
ATE443867T1 true ATE443867T1 (en) 2009-10-15

Family

ID=28792031

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03746054T ATE443867T1 (en) 2002-04-02 2003-03-27 METHOD FOR PREDICTING SEPSIS IN A PATIENT WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)

Country Status (6)

Country Link
US (1) US7465555B2 (en)
EP (1) EP1490789B1 (en)
JP (1) JP4520157B2 (en)
AT (1) ATE443867T1 (en)
DE (1) DE60329377D1 (en)
WO (1) WO2003084388A2 (en)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9468378B2 (en) 1997-01-27 2016-10-18 Lawrence A. Lynn Airway instability detection system and method
US8932227B2 (en) 2000-07-28 2015-01-13 Lawrence A. Lynn System and method for CO2 and oximetry integration
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US9521971B2 (en) 1997-07-14 2016-12-20 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US20070191697A1 (en) 2006-02-10 2007-08-16 Lynn Lawrence A System and method for SPO2 instability detection and quantification
US7184963B1 (en) * 1999-01-19 2007-02-27 Bristol-Myers Squibb Company Method for determining care and prevention pathways for clinical management of wounds
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US20060195041A1 (en) 2002-05-17 2006-08-31 Lynn Lawrence A Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
US20050288571A1 (en) * 2002-08-20 2005-12-29 Welch Allyn, Inc. Mobile medical workstation
WO2004044554A2 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
CN1829730A (en) * 2002-11-12 2006-09-06 贝克顿迪金森公司 Diagnosis of sepsis or SIRS using biomarker profiles
CA2505921A1 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
US20080070235A1 (en) * 2003-04-02 2008-03-20 Sirs-Lab Gmbh Method for Recognizing Acute Generalized Inflammatory Conditions (Sirs), Sepsis, Sepsis-Like Conditions and Systemic Infections
PT1708690T (en) 2003-11-17 2016-09-19 Biomarin Pharm Inc Treatment of phenylketonuria with bh4
WO2005048823A2 (en) * 2003-11-17 2005-06-02 Janssen Pharmaceutica N.V. Modeling of systemic inflammatory response to infection
DE102004009952B4 (en) * 2004-03-01 2011-06-01 Sirs-Lab Gmbh Method of detecting sepsis
WO2005092308A2 (en) 2004-03-25 2005-10-06 The Feinstein Institute For Medical Research Neural tourniquet
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
DE102004015605B4 (en) * 2004-03-30 2012-04-26 Sirs-Lab Gmbh Method for predicting the individual disease course in sepsis
DE102004049897B4 (en) * 2004-10-13 2007-11-22 Sirs-Lab Gmbh Method for distinguishing between non-infectious and infectious causes of multiple organ failure
WO2006055816A2 (en) 2004-11-19 2006-05-26 Trillium Diagnostics, Llc SOFTWARE INTEGRATED FLOW CYTOMETRIC ASSAY FOR QUANTIFICATION OF THE HUMAN POLYMORPHONUCLEAR LEUKOCYTE FcϜRI RECEPTOR (CD64)
AU2005323463B2 (en) 2004-12-27 2009-11-19 The Feinstein Institutes For Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US20060157647A1 (en) * 2005-01-18 2006-07-20 Becton, Dickinson And Company Multidimensional liquid chromatography/spectrometry
DE102005013013A1 (en) * 2005-03-21 2006-09-28 Sirs-Lab Gmbh Use of gene activity classifiers for the in vitro classification of gene expression profiles of patients with infectious / non-infectious multi-organ failure
BRPI0609302A2 (en) 2005-04-15 2011-10-11 Becton Dickinson Co methods for predicting the development of sepsis and for diagnosing sepsis in an individual to be tested, microarray, kit for predicting the development of sepsis in an individual to be tested, computer program product, computer, computer system for determining if an individual is likely to develop sepsis, digital signal embedded in a carrier wave, and, graphical user interface to determine if an individual is likely to develop sepsis
WO2007006091A1 (en) * 2005-07-07 2007-01-18 Athlomics Pty Ltd Polynucleotide marker genes and their expression, for diagnosis of endotoxemia
EP1904941A4 (en) * 2005-07-18 2009-10-21 Integralis Ltd Apparatus, method and computer readable code for forecasting the onset of potentially life-threatening disease
JP5183480B2 (en) 2005-09-28 2013-04-17 ベクトン・ディキンソン・アンド・カンパニー Detection of lysophosphatidylcholine for prognosis or diagnosis of systemic inflammatory conditions
DE102005050933A1 (en) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Invention relating to expression profiles for the prediction of septic states
US7668579B2 (en) 2006-02-10 2010-02-23 Lynn Lawrence A System and method for the detection of physiologic response to stimulation
US20070264663A1 (en) * 2006-05-02 2007-11-15 O'brien Peter J Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality
GB0610078D0 (en) * 2006-05-20 2006-06-28 Secr Defence Sepsis detection microarray
US20090104605A1 (en) * 2006-12-14 2009-04-23 Gary Siuzdak Diagnosis of sepsis
US8221995B2 (en) 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
US7682355B2 (en) * 2007-04-19 2010-03-23 Medtronic, Inc. Refined infection monitoring
US20080262331A1 (en) * 2007-04-19 2008-10-23 Medtronic, Inc. Infection monitoring
US7734353B2 (en) 2007-04-19 2010-06-08 Medtronic Inc. Controlling temperature during recharge for treatment of infection or other conditions
US20080262374A1 (en) * 2007-04-19 2008-10-23 Medtronic, Inc. Event triggered infection monitoring
US20080262332A1 (en) * 2007-04-19 2008-10-23 Medtronic, Inc. Infection monitoring
WO2008143890A2 (en) * 2007-05-14 2008-11-27 Children's Hospital Medical Center Biomarkers for septic shock patients
RU2475849C2 (en) * 2007-07-13 2013-02-20 Конинклейке Филипс Электроникс Н.В. System assisting in taking decisions for acute functional diseases
US8391970B2 (en) 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US20090208513A1 (en) * 2007-09-07 2009-08-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Diagnostic And Therapeutic Uses Of Augmenter Of Liver Regeneration In Inflammatory Conditions
GB0722729D0 (en) * 2007-11-20 2007-12-27 Bristol Myers Squibb Co Diagnostic markers of wound infection
DE102008000715B9 (en) 2008-03-17 2013-01-17 Sirs-Lab Gmbh Method for in vitro detection and differentiation of pathophysiological conditions
EP3432175A1 (en) * 2008-03-26 2019-01-23 Theranos IP Company, LLC Methods and systems for assessing clinical outcomes
AU2013231105B2 (en) * 2008-03-26 2016-07-07 Theranos Ip Company, Llc Methods and systems for assessing clinical outcomes
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9211409B2 (en) 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
CA2722773C (en) * 2008-05-07 2015-07-21 Lawrence A. Lynn Medical failure pattern search engine
US11728041B2 (en) 2008-05-07 2023-08-15 Lawrence A. Lynn Real-time time series matrix pathophysiologic pattern processor and quality assessment method
US8380531B2 (en) * 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
CA2740191A1 (en) * 2008-10-09 2010-04-15 Thomas Ryan A method of estimating risk of severe sepsis in an individual with infection
WO2010059617A2 (en) 2008-11-18 2010-05-27 Setpoint Medical Corporation Devices and methods for optimizing electrode placement for anti-inflamatory stimulation
US8788034B2 (en) 2011-05-09 2014-07-22 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US8507210B2 (en) * 2009-06-05 2013-08-13 B.R.A.H.M.S Gmbh Detection of bacterial infections in subjects suffering from dyspnea
WO2010144578A2 (en) 2009-06-09 2010-12-16 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
EP2309001A1 (en) 2009-09-23 2011-04-13 SIRS-Lab GmbH Method for in vitro recording and differentiation of pathophysiological states
DE102009044085A1 (en) 2009-09-23 2011-11-17 Sirs-Lab Gmbh Method for in vitro detection and differentiation of pathophysiological conditions
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
EP2515996B1 (en) 2009-12-23 2019-09-18 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
CN105572019B (en) * 2010-04-15 2018-12-21 洛伊克德克斯有限公司 For quickly determining the equipment, system and method for medical conditions
GB2482187A (en) 2010-07-23 2012-01-25 Univ Exeter Predicting response to surgery
FR2970975B1 (en) 2011-01-27 2016-11-04 Biomerieux Sa METHOD AND KIT FOR DETERMINING IN VITRO THE IMMUNE STATUS OF AN INDIVIDUAL
DE102011005235B4 (en) 2011-03-08 2017-05-24 Sirs-Lab Gmbh A method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for in vitro determination of a severity of the host response of a patient
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CA2863393C (en) 2012-02-07 2022-04-26 Hector R. Wong A multi-biomarker-based outcome risk stratification model for pediatric septic shock
US9267175B2 (en) 2012-02-07 2016-02-23 Children's Hospital Medical Center Multi-biomarker-based outcome risk stratification model for adult septic shock
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US9839396B2 (en) 2012-06-05 2017-12-12 Cheetah Medical, Inc. Method and system for assessing likelihood of sepsis
WO2014024176A1 (en) * 2012-08-09 2014-02-13 Koninklijke Philips N.V. Device for home monitoring of haematological parameters of patients
US9953453B2 (en) 2012-11-14 2018-04-24 Lawrence A. Lynn System for converting biologic particle density data into dynamic images
US10354429B2 (en) 2012-11-14 2019-07-16 Lawrence A. Lynn Patient storm tracker and visualization processor
JP6298474B2 (en) 2012-12-17 2018-03-20 レウコドゥックス，リミテッド Systems and methods for detecting biological conditions
US10610861B2 (en) 2012-12-17 2020-04-07 Accellix Ltd. Systems, compositions and methods for detecting a biological condition
US20140170678A1 (en) 2012-12-17 2014-06-19 Leukodx Ltd. Kits, compositions and methods for detecting a biological condition
US9759722B2 (en) * 2012-12-17 2017-09-12 Leukodx Ltd. Systems and methods for determining a chemical state
GB201301611D0 (en) * 2013-01-30 2013-03-13 Shaw Andrew M Systems and methods for medical data processing and analysis
WO2014134557A1 (en) 2013-02-28 2014-09-04 Lynn Lawrence A System for presentation of sequential blood laboratory measurements to image recognition systems
AU2014299322B2 (en) * 2013-06-28 2018-08-09 Acumen Research Laboratories Pte. Ltd. Sepsis biomarkers and uses thereof
EP3030576A4 (en) * 2013-08-07 2017-04-05 University Of Rochester Method of diagnosing sepsis or sepsis risk
WO2015077781A1 (en) 2013-11-25 2015-05-28 Children's Hospital Medical Center Temporal pediatric sepsis biomarker risk model
JP6355154B2 (en) * 2014-04-03 2018-07-11 公益財団法人ヒューマンサイエンス振興財団 Diagnosis assistance method
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10261068B2 (en) 2015-06-04 2019-04-16 Children's Hospital Medical Center Persevere-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
EP3405107B1 (en) 2016-01-20 2023-04-12 Setpoint Medical Corporation Control of vagal stimulation
WO2017127758A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Implantable microstimulators and inductive charging systems
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
RU2653631C2 (en) * 2016-10-05 2018-05-11 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Method for lethality forecast for pulmonary-septic infections in experiment
WO2019036470A1 (en) 2017-08-14 2019-02-21 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
CN109030815B (en) * 2018-06-26 2021-08-10 安徽医科大学 Protein chip for detecting liquid phase protein interaction and preparation method and application thereof
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
WO2020257358A1 (en) * 2019-06-17 2020-12-24 The Broad Institute, Inc. Immune cell signature for bacterial sepsis
IL298193B2 (en) 2020-05-21 2024-01-01 Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1504597A1 (en) 1986-06-25 1989-08-30 Актюбинский государственный медицинский институт Method of differential diagnosis of sepsis and localized purulent infection in newborn infants
DE59009571D1 (en) * 1989-07-01 1995-10-05 Barmag Barmer Maschf False twist crimping machine for a synthetic thread.
EP0571442A4 (en) * 1991-01-14 1995-05-03 Univ New York Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof.
DE4227454C1 (en) 1992-08-19 1994-02-03 Henning Berlin Gmbh Process for early detection, for the detection of the severity as well as for the therapy-accompanying assessment of the course of sepsis as well as means for carrying out the process
RU2072103C1 (en) 1993-06-10 1997-01-20 Ростовский научно-исследовательский институт акушерства и педиатрии Method of diagnosis of bacterial infections in newborns
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US6190872B1 (en) * 1994-05-06 2001-02-20 Gus J. Slotman Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method
US5804370A (en) * 1994-06-08 1998-09-08 Critichem Medical Products Limited Early diagnosis of sepsis utilizing antigen-antibody interactions amplified by whole blood chemiluminescence
US5566249A (en) * 1994-09-20 1996-10-15 Neopath, Inc. Apparatus for detecting bubbles in coverslip adhesive
US5780237A (en) * 1994-10-12 1998-07-14 Cell Therapeutics, Inc. Sepsis, adult respiratory distress syndrome, and systemic inflammatory response syndrome diagnostic
US5830679A (en) * 1996-03-01 1998-11-03 New England Medical Center Hospitals, Inc. Diagnostic blood test to identify infants at risk for sepsis
US6077665A (en) * 1996-05-07 2000-06-20 The Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in neonates
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
ES2287115T3 (en) * 2000-03-28 2007-12-16 Trustees Of Dartmouth College PROCEDURE FOR THE DETECTION OF INFLAMMATION AND INFLAMMATORY STATES.
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis

Also Published As

Publication number Publication date
WO2003084388A3 (en) 2004-08-12
US20030194752A1 (en) 2003-10-16
WO2003084388A2 (en) 2003-10-16
JP2005521882A (en) 2005-07-21
DE60329377D1 (en) 2009-11-05
EP1490789B1 (en) 2009-09-23
EP1490789A4 (en) 2006-08-30
EP1490789A2 (en) 2004-12-29
US7465555B2 (en) 2008-12-16
JP4520157B2 (en) 2010-08-04

Similar Documents

Publication Publication Date Title
ATE443867T1 (en) METHOD FOR PREDICTING SEPSIS IN A PATIENT WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)
TW200616578A (en) Fluid handling devices
WO2007126444A3 (en) Analyte monitoring
WO2007041245A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
ATE539675T1 (en) SYSTEM AND METHOD FOR DETERMINING AN ANALYTE CONCENTRATION WITH HEMATOCRIT CORRECTION
WO2005048823A3 (en) Modeling of systemic inflammatory response to infection
DE602005022704D1 (en) SENSOR FOR SEVERAL ANALYTICS
WO2008070137A3 (en) Interferon alpha-induced pharmacodynamic markers
FI20041323A0 (en) Analyzer, system, and method for determining the desired user population
ATE459883T1 (en) NEW PROLIFERATION MARKERS IN CLINICAL PRACTICE AND THEIR USE FOR CANCER PROGNOSIS OR DIAGNOSIS
BRPI0307697A2 (en) method for monitoring, estimating and constructing equations for estimating the concentration of a selected analyte within a sample, method for determining the volume of a sample and a set of environmental factors present in an electrochemical system, apparatus and method for determination of the identity of a sample in electrolyte contact with an electrochemical system
JP2010506147A5 (en)
ATE493645T1 (en) ELECTROCHEMICAL SENSOR FOR DETERMINING AN ANALYTE CONCENTRATION
ATE508364T1 (en) DIAGNOSTIC PROCEDURES FOR PREECLAMPSIA
ATE557101T1 (en) METHODS AND COMPOSITIONS FOR DETERMINING A TRANSPLANTATION TOLERANT PHENOTYPE IN AN INDIVIDUAL
NZ551782A (en) Agents and methods for diagnosing stress
CA2510377A1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
NO20081343L (en) Biosensor measuring device, biosensor measuring system and biosensor measuring method
DE502004009217D1 (en) Differential diagnosis with hepcidin
DE602006015221D1 (en) METHOD FOR DIAGNOSIS OF SEPSIS BY ANALYSIS OF CYTOKINE MRNA EXPRESSION
BRPI0512655A (en) rna bioassay
DE60323677D1 (en) METHOD FOR DETERMINING THE REPRODUCTION OF PROSTATE CANCER
DE602004029156D1 (en) FORECAST OF THE CURRENT OF CANCER DISEASE
DK1687636T3 (en) Rapid determination of various forms of hepatocyte growth factor (HGF) in body fluids
ATE537455T1 (en) MONOCLONAL AND POLYCLONAL ANTIBODIES TO UNGULATE ALBUMINE AND HEMOGLOBIN AND APPARATUS AND METHOD USING THE ANTIBODIES IN DETECTING AND FINDING ULCERS AND OTHER DIGESTIVE DISEASES AND BLEEDING IN UNGARES

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties